[Pulmonary vascular interventions: innovating through adaptation and advancing through differentiation]

Area of Science:

• Cardiology
• Interventional Pulmonology
• Medical Technology

Background:

• Pulmonary vascular diseases require effective treatment options.
• Minimally invasive techniques are advancing medical interventions.
• Existing coronary intervention techniques need adaptation for pulmonary circulation.

Purpose of the Study:

• To review the advancements in pulmonary vascular intervention technology.
• To highlight techniques like BPA, stenting, and PADN for pulmonary vascular diseases.
• To discuss future directions and the potential of these interventions.

Main Methods:

• Review of current pulmonary vascular intervention techniques.
• Comparison with coronary intervention (PCI) principles.
• Analysis of challenges and modifications for pulmonary circulation.
• Exploration of emerging technologies and future research.

Main Results:

• Pulmonary vascular interventions, including balloon pulmonary angioplasty (BPA), pulmonary artery stenting, and percutaneous pulmonary artery denervation (PADN), show significant promise.
• These techniques have improved prognoses for chronic thromboembolic pulmonary hypertension (CTEPH), pulmonary artery stenosis, and pulmonary arterial hypertension (PAH).
• Adaptations are necessary to manage the low-pressure, thin-walled nature of pulmonary vessels and mitigate risks like perforation and thrombosis.

Conclusions:

• Pulmonary vascular intervention technology is a rapidly evolving field with minimally invasive advantages.
• Further development in instruments, imaging, AI, and molecular therapies is crucial.
• These innovations could elevate pulmonary vascular interventions from adjuvant to core treatments.